Effects of exogenous ubiquitin in a polytrauma model with blunt chest trauma

Critical Care Medicine

Volumn 40, Issue 8, 2012, Pages 2376-2384

  Baker, Todd A ^a   Romero, Jacqueline ^a   Bach, Harold H ^a   Strom, Joel A ^c   Gamelli, Richard L ^a   Majetschak, Matthias ^a,b  

^a Burn and Shock Trauma Institute   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

blunt chest trauma; CXC chemokine receptor 4; exogenous ubiquitin; femur fractures; organ protection; resuscitation; stromal cell derived factor 1a

Indexed keywords

4 HYDROXYALKENAL; ALDEHYDE; BOVINE SERUM ALBUMIN; CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LACTIC ACID; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; STROMAL CELL DERIVED FACTOR 1ALPHA; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTERIAL BLOOD; ARTERIAL OXYGEN SATURATION; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; ENZYME PHOSPHORYLATION; EXPERIMENTAL MODEL; EXPERIMENTAL PIG; HEART; JEJUNUM; LACTATE BLOOD LEVEL; LIPID PEROXIDATION; LUNG INJURY; LUNG WEIGHT; MEAN ARTERIAL PRESSURE; MULTIPLE TRAUMA; NONHUMAN; PRIORITY JOURNAL; RESUSCITATION; SHOCK; SPLEEN; THORAX BLUNT TRAUMA; TISSUE LEVEL; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMORAL FRACTURES; LIPID PEROXIDATION; MALE; MULTIPLE TRAUMA; RECEPTORS, CXCR4; SWINE; THORACIC INJURIES; UBIQUITIN; WOUNDS, NONPENETRATING;

EID: 84864290127     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3182514ed9     Document Type: Article

References (45)

1. Hershko A, Ciechanover A: The ubiquitin system. Annu Rev Biochem 1998; 67:425-479. (Pubitemid 28411135)
2. Majetschak M: Extracellular ubiquitin: Immune modulator and endogenous opponent of damage-associated molecular pattern molecules. J Leukoc Biol 2011; 89:205-219.
3. Majetschak M, Krehmeier U, Bardenheuer M, et al: Extracellular ubiquitin inhibits the TNF-alpha response to endotoxin in peripheral blood mononuclear cells and regulates endotoxin hyporesponsiveness in critical illness. Blood 2003; 101:1882-1890. (Pubitemid 36237589)
4. Saini V, Marchese A, Majetschak M: CXC chemokine receptor 4 is a cell surface receptor for extracellular ubiquitin. J Biol Chem 2010; 285:15566-15576.
5. Saini V, Marchese A, Tang WJ, et al: Structural determinants of ubiquitin-CXC chemokine receptor 4 interaction. J Biol Chem 2011; 286:44145-44152.
6. Saini V, Staren DM, Ziarek JJ, et al: The CXC chemokine receptor 4 ligands ubiquitin and stromal cell-derived factor-1? function through distinct receptor interactions. J Biol Chem 2011; 286:33466-33477.
7. Majetschak M, Zedler S, Hostmann A, et al: Systemic ubiquitin release after blunt trauma and burns: Association with injury severity, posttraumatic complications, and survival. J Trauma 2008; 64:586-596; discussion 596. (Pubitemid 351366873)
8. Majetschak M, Cohn SM, Nelson JA, et al: Effects of exogenous ubiquitin in lethal endotoxemia. Surgery 2004; 135:536-543. (Pubitemid 38586528)
9. Majetschak M, Cohn SM, Obertacke U, et al: Therapeutic potential of exogenous ubiquitin during resuscitation from severe trauma. J Trauma 2004; 56:991-999; discussion 999.
10. Earle SA, El-Haddad A, Patel MB, et al: Prolongation of skin graft survival by exogenous ubiquitin. Transplantation 2006; 82:1544-1546. (Pubitemid 44967642)
11. Earle SA, Proctor KG, Patel MB, et al: Ubiquitin reduces fluid shifts after traumatic brain injury. Surgery 2005; 138:431-438. (Pubitemid 41415569)
12. Griebenow M, Casalis P, Woiciechowsky C, et al: Ubiquitin reduces contusion volume after controlled cortical impact injury in rats. J Neurotrauma 2007; 24:1529-1535. (Pubitemid 47493516)
13. Garcia-Covarrubias L, Manning EW 3rd, Sorell LT, et al: Ubiquitin enhances the Th2 cytokine response and attenuates ischemiareperfusion injury in the lung. Crit Care Med 2008; 36:979-982.
14. Ahn HC, Yoo KY, Hwang IK, et al: Ischemiarelated changes in naive and mutant forms of ubiquitin and neuroprotective effects of ubiquitin in the hippocampus following experimental transient ischemic damage. Exp Neurol 2009; 220:120-132.
15. Goelz L, Casalis PA, Thomale UW, et al: The effect of ubiquitin on immune response after controlled cortical impact injury. J Trauma 2011; 70:1104-1111.
16. Singh M, Roginskaya M, Dalal S, et al: Extracellularubiquitin inhibits beta-AR-stimulated apoptosis in cardiac myocytes: Role of GSK-3beta and mitochondrial pathways. Cardiovasc Res 2010; 86:20-28.
17. Jaremko L, Jaremko M, Pasikowski P, et al: The immunosuppressive activity and solution structures of ubiquitin fragments. Biopolymers 2009; 91:423-431.
18. Hildebrand F, Giannoudis PV, Griensven M, et al: Management of polytraumatized patients with associated blunt chest trauma: A comparison of two European countries. Injury 2005; 36:293-302. (Pubitemid 40138673)
19. Bardenheuer M, Obertacke U, Waydhas C, et al: [Epidemiology of the severely injured patient. A prospective assessment of preclinical and clinical management. AG Polytrauma of DGU]. Unfallchirurg 2000; 103:355-363.
20. Greenspan L, McLellan BA, Greig H: Abbreviated Injury Scale and Injury Severity Score: A scoring chart. J Trauma 1985; 25:60-64. (Pubitemid 15169712)
21. Dudkiewicz M, Harpaul TA, Proctor KG: Hemoglobin-based oxygen carrying compound-201 as salvage therapy for severe neuro-and polytrauma (Injury Severity Score = 27-41). Crit Care Med 2008; 36:2838-2848.
22. Baker TA, Romero J, Bach HH 4th, et al: Systemic release of cytokines and heat shock proteins in porcine models of polytrauma and hemorrhage. Crit Care Med 2012; 40:876-885.
23. Geng Q, Romero J, Saini V, et al: A subset of 26S proteasomes is activated at critically low ATP concentrations and contributes to myocardial injury during cold ischemia. Biochem Biophys Res Commun 2009; 390:1136-1141.
24. Majetschak M, Patel MB, Sorell LT, et al: Cardiac proteasome dysfunction during cold ischemic storage and reperfusion in a murine heart transplantation model. Biochem Biophys Res Commun 2008; 365:882-888. (Pubitemid 350234876)
25. Lowry OH, Rosebrough NJ, Farr AL, et al: Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-275.
26. Cane RD, Buchanan N: The electrocardiographic and clinical diagnosis of myocardial contusion. Intensive Care Med 1978; 4:99-102. (Pubitemid 8301558)
27. Nagasawa M, Sakimura K, Mori KJ, et al: Gene structure and chromosomal localization of the mouse NMDA receptor channel subunits. Brain Res Mol Brain Res 1996; 36:1-11. (Pubitemid 26058870)
28. Regard JB, Sato IT, Coughlin SR: Anatomical profiling of G protein-coupled receptor expression. Cell 2008; 135:561-571.
29. Xiao Q, Ye S, Oberhollenzer F, et al: SDF1 gene variation is associated with circulating SDF1alpha level and endothelial progenitor cell number: The Bruneck Study. PLoS ONE 2008; 3:e4061.
30. Becchi C, Pillozzi S, Fabbri LP, et al: The increase of endothelial progenitor cells in the peripheral blood: A new parameter for detecting onset and severity of sepsis. Int J Immunopathol Pharmacol 2008; 21:697-705.
31. Fox A, Smythe J, Fisher N, et al: Mobilization of endothelial progenitor cells into the circulation in burned patients. Br J Surg 2008; 95:244-251.
32. Saini V, Romero J, Marchese A, et al: Ubiquitin receptor binding and signaling in primary human leukocytes. Commun Integr Biol 2010; 3:608-610.
33. Karin N: The multiple faces of CXCL12 (SDF-1alpha) in the regulation of immunity during health and disease. J Leukoc Biol 2010; 88:463-473.
34. Fricker SP, Anastassov V, Cox J, et al: Characterization of the molecular pharmacology of AMD3100: A specific antagonist of the G-protein coupled chemokine receptor, CXCR4. Biochem Pharmacol 2006; 72:588-596. (Pubitemid 44163295)
35. . Hesselgesser J, Liang M, Hoxie J, et al: Identification and characterization of the CXCR4 chemokine receptor in human T cell lines: Ligand binding, biological activity, and HIV-1 infectivity. J Immunol 1998; 160:877-883. (Pubitemid 28049330)
36. Loetscher P, Gong JH, Dewald B, et al: N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities. J Biol Chem 1998; 273:22279-22283. (Pubitemid 28399785)
37. Bernhagen J, Krohn R, Lue H, et al: MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 2007; 13:587-596. (Pubitemid 46828480)
38. Di Salvo J, Koch GE, Johnson KE, et al: The CXCR4 agonist ligand stromal derived factor-1 maintains high affinity for receptors in both Galpha(i)-coupled and uncoupled states. Eur J Pharmacol 2000; 409:143-154.
39. Hesselgesser J, Halks-Miller M, DelVecchio V, et al: CD4-independent association between HIV-1 gp120 and CXCR4: Functional chemokine receptors are expressed in human neurons. Curr Biol 1997; 7:112-121. (Pubitemid 27155620)
40. Villalba S, Salvucci O, Aoki Y, et al: Serum inactivation contributes to the failure of stromal-derived factor-1 to block HIV-I infection in vivo. J Leukoc Biol 2003; 74:880-888. (Pubitemid 38040364)
41. Antonsson B, De Lys P, Dechavanne V, et al: In vivo processing of CXCL12a/SDF-1a after intravenous and subcutaneous administration to mice. Proteomics 2010; 10:4342-4351.
42. Fan H, Wong D, Ashton SH, et al. Beneficial effect of a CXCR4 agonist in murine models of systemic inflammation. Inflammation 2012; 35:130-137.
43. Kanki S, Segers VF, Wu W, et al: Stromal cellderived factor-1 retention and cardioprotection for ischemic myocardium. Circ Heart Fail 2011; 4:509-513.
44. Hu X, Dai S, Wu WJ, et al: Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: Role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation 2007; 116:654-663. (Pubitemid 47356350)
45. Meiron M, Zohar Y, Anunu R, et al: CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells. J Exp Med 2008; 205:2643-2655.